|
EP1785411A1
|
|
Protriptyline hydrochloride crystalline form
|
|
EP1777224A2
|
|
A process for the preparation of angiotensin II antagonistic compounds
|
|
EP1777295A2
|
|
A process for the preparation of (-) modafinil
|
|
EP1759758A1
|
|
A process for destructively scrubbing methyl chloride gas
|
|
EP1743896A2
|
|
A process for the purification of imiquimod
|
|
EP1726595A1
|
|
Crystalline form of fosinopril calcium
|
|
EP1707565A1
|
|
Losartan potassium crystalline form alpha
|
|
EP1700857A1
|
|
Ziprasidone free from colored impurities and a process for its preparation
|
|
EP1674463A1
|
|
Rabeprazole sodium salt in crystalline hydrate form
|
|
EP1661878A1
|
|
Adapalene polymorphic forms
|
|
EP1621532A1
|
|
Fexofenadine base polymorphic forms
|
|
EP1616861A2
|
|
A process for the preparation of keto compounds
|
|
JP2005350459A
|
|
Polymorph of fexofenadine and method for producing the same
|
|
EP1751148A1
|
|
Ziprasidone hydrochloride polymorph and process for its preparation
|
|
EP1598347A1
|
|
Polymorphs of pantoprazole sodium salt and process for the preparation thereof
|
|
US2007191439A1
|
|
Intermediates for the preparation of pramipexole
|
|
EP1544198A1
|
|
A process for the preparation of crystalline losartan potassium
|
|
IL164979D0
|
|
A process for the preparation of benazepril, hydrochloride
|
|
EP1529781A1
|
|
A process for the preparation of Imiquimod and intermediates thereof
|
|
EP1548009A2
|
|
Process for the preparation of benzylimidazole derivatives and for losartan.
|
